iShares Nasdaq Biotechnology ETF Stock Forecast, Price & News

+0.71 (+0.41 %)
(As of 09/16/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume1.83 million shs
Average Volume3.17 million shs
Market Capitalization$11.08 billion
P/E RatioN/A
Dividend Yield0.16%
30 days | 90 days | 365 days | Advanced Chart
Receive IBB News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer BlackRock
Fund NameiShares Nasdaq Biotechnology ETF
Tax ClassificationRegulated Investment Company
Inception Date2/5/2001
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason

Fund Focus

Asset ClassEquity
BenchmarkNASDAQ Biotechnology Index
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$7.70 billion
Average Daily Volume$2.62 million

ETF Expenses

Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Lead Market MakerVirtu Financial

Geographic Exposure of IBB

Currency Exposure of IBB

Sector Exposure of IBB

Industry Exposure of IBB

speech bubbles
speech bubbles

iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions

What stocks does MarketBeat like better than iShares Nasdaq Biotechnology ETF?

Wall Street analysts have given iShares Nasdaq Biotechnology ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iShares Nasdaq Biotechnology ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting iShares Nasdaq Biotechnology ETF?

iShares Nasdaq Biotechnology ETF saw a drop in short interest during the month of August. As of August 13th, there was short interest totaling 11,400,000 shares, a drop of 12.6% from the July 29th total of 13,050,000 shares. Based on an average daily trading volume, of 3,063,600 shares, the short-interest ratio is currently 3.7 days.
View iShares Nasdaq Biotechnology ETF's Short Interest

How has iShares Nasdaq Biotechnology ETF's stock price been impacted by COVID-19?

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IBB stock has increased by 61.3% and is now trading at $172.51.
View which stocks have been most impacted by COVID-19

Is iShares Nasdaq Biotechnology ETF a good dividend stock?

iShares Nasdaq Biotechnology ETF pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.16%.
View iShares Nasdaq Biotechnology ETF's dividend history.

When did iShares Nasdaq Biotechnology ETF's stock split? How did iShares Nasdaq Biotechnology ETF's stock split work?

iShares Nasdaq Biotechnology ETF shares split on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

Who are iShares Nasdaq Biotechnology ETF's key executives?

iShares Nasdaq Biotechnology ETF's management team includes the following people:
  • George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
  • Michael Arthur Latham, President, Trustee
  • Jack Gee, Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
  • , Bio & Compensation - 
  • Amy Schioldager, Executive Vice President
  • Ira P. Shapiro, Vice President, Chief Legal Officer
  • Matt Tucker, Vice President
  • , Bio & Compensation - 
  • Eilleen M. Clavere, Secretary
  • Cecilia H. Herbert, Independent Trustee
  • Charles A. Hurty, Independent Trustee

Who are some of iShares Nasdaq Biotechnology ETF's key competitors?

What other stocks do shareholders of iShares Nasdaq Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), The Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

What is iShares Nasdaq Biotechnology ETF's stock symbol?

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

Who are iShares Nasdaq Biotechnology ETF's major shareholders?

iShares Nasdaq Biotechnology ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Jefferies Group LLC (0.00%), Morgan Stanley (5.11%), Goldman Sachs Group Inc. (2.94%), Citigroup Inc. (2.74%), BNP Paribas Arbitrage SA (2.73%) and Vision Capital Corp (0.00%).

Which institutional investors are selling iShares Nasdaq Biotechnology ETF stock?

IBB stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Goldman Sachs Group Inc., Healthcare of Ontario Pension Plan Trust Fund, Elliott Investment Management L.P., JPMorgan Chase & Co., PFM Health Sciences LP, Susquehanna International Group LLP, and Citigroup Inc..

Which institutional investors are buying iShares Nasdaq Biotechnology ETF stock?

IBB stock was purchased by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Vision Capital Corp, Liberty Wealth Management LLC, Ergoteles LLC, Bank of Nova Scotia, Total Investment Management Inc., Twin Tree Management LP, and BNP Paribas Arbitrage SA.

How do I buy shares of iShares Nasdaq Biotechnology ETF?

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Nasdaq Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $172.51.

How much money does iShares Nasdaq Biotechnology ETF make?

iShares Nasdaq Biotechnology ETF has a market capitalization of $11.08 billion.

This page was last updated on 9/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.